Klaus Lieb

Prof. Klaus Lieb, MD (*1965) is Scientific Director of the Leibniz Institute for Resilience Research (LIR) and Professor and Chair of the Department of Psychiatry and Psychotherapy at the University Medical Centre in Mainz, Germany. His fields of expertise are systematic reviews and meta-analyses on resilience mechanisms and interventions as well as the development of psychotherapeutic, pharmacological, and other methods for promoting resilience on the basis of resilience mechanisms that are investigated in long-term studies. He recently published several landmark papers on psychological resilience during the COVID-19 pandemic with high relevance for pandemic preparedness. In this field, he is active in several initiatives to promote pandemic preparedness in Germany and pushes the idea of interdisciplinary approaches for better societal resilience to pandemics. His clinical research interests are also into the neurobiology and psychopharmacotherapy of affective disorders and disorders of impulse control including borderline personality disorder as well as research into conflicts of interest in medicine. He studied medicine and philosophy at the Universities of Ulm, Tübingen and Los Angeles, became a medical doctor in 1992, worked at the universities of Ulm and Freiburg and became vice chair of the Department of Psychiatry and Psychotherapy at the University of Freiburg, Germany, in 2001. Since 2007 he is head of the Department of Psychiatry and Psychotherapy, University of Mainz, Germany. He became the Scientific Director of the former German Resilience Center (DRZ) in 2018, which was integrated into the Leibniz Association and renamed to LIR in 2020. Prof Lieb won several awards and published more than 300 original scientific papers, more than 70 reviews and letters and more than 20 books and book chapters